期刊文献+

479例肝细胞癌先证者家族聚集性分析 被引量:4

Familial aggregation in first-degree relatives of 479 probands with hepatocellular carcinoma
下载PDF
导出
摘要 目的通过肝细胞癌(HCC)先证者一级亲属发病调查情况,探讨HCC病例分布的家族聚集性的特点。方法应用临床流行病学横断面研究方法,对2004~2008年广西医科大学附属肿瘤医院HCC先证者家系中一级亲属HCC发病情况进行调查,回顾性采用Poisson(泊松)分布模型拟合,并用频数分布拟合优度的χ2检验进行验证。对有家族史的HCC分布用二项分布(p+q)n模型拟合。HCC分离比采用Li-Mantel-Gart法估算。结果 HCC先证者479例,占住院人数16.91%(479/2832)。该家族中实际病例数分布超越了二项分布的概率范围(P=0.028)。HCC的分离比为0.04,分离比方差为0.00001509,标准误为0.003885,95%可信限区间:0.033784~0.046216。结论 HCC发病具有家族聚集现象,主要集中在一级亲属,HCC的遗传方式为多基因遗传,HCC先证者家系是HCC发病的危险因素之一。 Objective To investigate the prevalence of hepatocellular carcinoma(HCC )among first-degree relatives and explore the familial aggregation of HCC. Methods A cross-sectional study was performed on first-degree relatives of HCC probands treated at the Affiliated Cancer Hospital of Guangxi Medical University from 2004 to 2008.The binomial distribution model was applied to test the goodness-of-fit of the frequency distribution.Resuhs There were 479 probands, accounting for 16.91% (479/2 832) of hospital admis- sions. Results of binominal distribution analysis showed that the number of HCC cases within proband families was significantly higher than the theoretical range(P=0.028).The estimated separation ratio of HCC was 0.04,and the separation ratio variance was 0.000 015 09(SD=0.003 885,95%CI: 0.033 784-0.046 216). Conclusion HCC shows significant familial aggregation in first-degree relatives of probands, and family history is one of the important risk factors for HCC.
出处 《中国癌症防治杂志》 CAS 2012年第2期187-190,共4页 CHINESE JOURNAL OF ONCOLOGY PREVENTION AND TREATMENT
基金 广西壮族自治区卫生厅重点科研课题(重200975)
关键词 肝肿瘤 临床流行病学 横断面研究 二项分布 Liver neoplasms Clinical epidemiology Cross-sectional study Binomial distribution
  • 相关文献

参考文献12

  • 1Perz JF, Armstrong GL, Farrington LA, et al. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide[J]. J Hepatol,2006,45(4) : 529-538.
  • 2吴继周,李国坚,陈务卿,臧宁,吴健林,玉艳红,陈茂伟,韦颖华,万裴琦,胡蝶飞,宁秋悦,贺荣.广西新发现肝癌高发点的初步流行病学研究[J].内科,2009,4(5):678-680. 被引量:28
  • 3Vogelstein B, Kinzler KW.Cancer genes and the pathways they control [J]. Nat Meal,2004,10(8) : 789-799.
  • 4Hanahan D,Weinberg RA.Hallmarks of cancer:the next generation [ J ].Cell. 2011,144( 5 ) : 646-674.
  • 5Jemal A,Bray F,Center MM,et al.Global cancer statistics[ J ]. CA Cancer J Clin,2011, 61(2) :69-90.
  • 6Ferlay J, Shin HR, Bray F, et al.Estimates of worldwide burden of cancer in 2008:GLOBOCAN 2008[J].Int J Cancer,2010,127(12) : 2893-2917.
  • 7莫显伟,林源.VEGF阳性表达与肝癌术后复发相关性的研究[J].中国癌症防治杂志,2009,1(3):221-222. 被引量:5
  • 8Yoo BK,Emdad L,Su ZZ,et al. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression [ J ].J Clin Invest, 2009,119 (3) : 465- 477.
  • 9Lee SG,Su ZZ, Emdad L,et al.Astrocyte elevated gene-I activates cell survival pathways through PI3K-Akt signaling[J].Oncogene, 2008,27(8):1114-1121.
  • 10白涛,齐鲁楠,黎乐群.乙肝病毒/黄曲霉毒素双暴露人原发性肝细胞癌中p53、p21的表达及意义[J].中国癌症防治杂志,2010,2(4):254-257. 被引量:3

二级参考文献21

  • 1丛文铭.肝细胞癌克隆起源的分子病理学研究进展[J].中华病理学杂志,1995,24(2):116-119. 被引量:13
  • 2乔宗恺,赵梅,尹厚源,车锡嘏,杜其筠,黄惠琪,吴富铭,谢铭英.遗传因素对原发性肝癌发病影响的初步探讨[J].遗传与疾病,1989,6(3):137-139. 被引量:3
  • 3吴继周,叶馥荪,莫志纯.广西原发性肝细胞癌病因探讨——118例配对病例—对照的条件Logistic回归分析[J].癌症,1990,9(1):25-28. 被引量:15
  • 4El-Deiry WS,Tokino T,Velculescu VE,et al.WAF1,apotential mediator of p53 tumor suppression[J].Cell,1993,75:817-825.
  • 5Zhang W,Grasso L,McClain CD,et al.p53 independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differention[J].Cancer Res,1995,55(3):668-674.
  • 6Huy TT & Abe K.Molecular epidemiology of hepatitis B and C virus infections in Asia[J].Pediatr Int,2004,46:223-230.
  • 7Groopman JD & Kensler TW.Role of metabolism and viruses in aflatoxin-induced liver cancer[J].Toxicol Appl Pharmacol,2005,206:131-137.
  • 8Marchetti A,Doglioni C,Barbareschi M,et al.p21 RNA and protein expression in non-small cell lung carcinomas:evidence of p53-independent expression and association with tumoral differentiation[J].Oncogene,1996,12:1391-1324.
  • 9Tron VA,TAng L,Long WP,et al.Differentiation associated overexpression of the cyclin-dependent kinase inhibitor p21 WAF1 in human cutaneous squamous cell carcinoma[J].Am J Pathol,1996,149:1139-1146.
  • 10Crary GS,Albrecht JH.Expression of cyclin-dependent kinase inhibitor p21 in human liver[J].Hepatology,1998,28(3):738-743.

共引文献33

同被引文献27

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部